EGFR-TKIs plus stereotactic body radiation therapy (SBRT) for stage IV Non-small cell lung cancer (NSCLC): A prospective, multicenter, randomized, controlled phase II study
- Resource Type
- Article
- Source
- In
Radiotherapy and Oncology July 2023 184 - Subject
- Language
- ISSN
- 0167-8140